Recent advancements in cancer immunotherapy have highlighted glypican-3 (GPC3) as a prominent target for treating hepatocellular carcinoma (HCC). However, approximately 10% to 30% of HCC patients ...
Researchers at Institute of Science Tokyo created a mouse model of the aggressive subtype of HCC and provided insights into its underlying molecular mechanism. Using these insights, they demonstrated ...
USA: A large real-world analysis published in JAMA Network Open offers new insights into how systemic treatment strategies ...
Frontline setting accelerates potential for deep, durable responses in the treatment of liver cancers Study builds on clinical validation from one of the largest datasets in the in vivo CAR field ...
MedPage Today on MSN
Liver cancer treatment landscape shifts rapidly, but best sequencing still unclear
Immunotherapy-based combinations have rapidly become the dominant first-line treatment for advanced hepatocellular carcinoma (HCC), but real-world outcomes remain heavily constrained by liver function ...
SHANGHAI and SAN FRANCISCO, Jan. 12, 2026 /PRNewswire/ -- Oricell Therapeutics Holdings Limited ("Oricell" or "the Company"), a global leader in innovative cancer immunotherapy, announced today the ...
This Research Topic is part of the series of "Hepatocellular Carcinoma: Novel Treatment Strategies":Hepatocellular Carcinoma: Novel Treatment Strategies - ...
Abscopal effect refers to the shrinkage or regression of metastatic tumours that are distant from the irradiated field.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback